- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- BioMed Realty (NYSE: BMR) hit a new 52-week high Thursday as it is currently trading at $22.21, above its previous 52-week high of $21.97 with 470,329 shares traded as of 11:03 a.m. ET. Average volume has been 1.3 million shares over the past 30 days. BioMed has a market cap of $3.38 billion and is part of the financial sector and real estate industry. Shares are up 13.2% year to date as of the close of trading on Wednesday. BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. The company has a P/E ratio of 289.9, above the S&P 500 P/E ratio of 17.7.